发明名称 Recombinant anti-interleukin-9-antibody
摘要 <p>The application describes neutralizing chimeric and humanized anti-human IL-9 antibodies, and the use thereof to identify neutralizing epitopes on human IL-9 and as medicaments to prevent and treat asthma, bronchial hyperresponsiveness, atopic allergy, and other related disorders. Particularly disclosed are recombinant antibodies derived from three murine anti-human IL-9 antibodies identified infra as MH9A3, MH9D1, and MH9L1.</p>
申请公布号 EP2270049(A2) 申请公布日期 2011.01.05
申请号 EP20100009197 申请日期 2003.04.11
申请人 MEDIMMUNE, INC.;LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. 发明人 REED, JENNIFER LYNNE;DALL'ACQUA, WILLIAM;VAN SNICK, JACQUES;RENAULD, JEAN-CHRISTOPHE;CORMONT, FRANCOISE;UYTTENHOVE, CATHERINE
分类号 C07K16/24;C12N15/09;A61K39/395;A61P1/04;A61P1/16;A61P3/10;A61P5/00;A61P5/14;A61P7/00;A61P7/04;A61P7/06;A61P9/00;A61P9/14;A61P11/00;A61P11/06;A61P11/08;A61P13/12;A61P15/08;A61P17/00;A61P17/04;A61P19/00;A61P19/02;A61P21/00;A61P21/04;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P35/02;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07K14/54;C07K19/00;C12P21/08 主分类号 C07K16/24
代理机构 代理人
主权项
地址